Crinetics Pharmaceuticals (CRNX) Research & Development (2017 - 2026)
Crinetics Pharmaceuticals' Research & Development came in at $99.85 million for Q2 2026, up 24.3% from $80.3 million a year earlier but down 0.2% from the prior quarter.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Research & Development (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Crinetics Pharmaceuticals reported Research & Development of $375.45 million, up 31.7% year-over-year; for FY2025, it came in at $332.06 million, up 38.3% from FY2024.
- Research & Development has increased in each of the last nine years, with a five-year compound annual growth rate of 42.3% (FY2020 to FY2025).
- Going back by year, Research & Development was $240.16 million in FY2024 (+42.5%), $168.53 million in FY2023 (+29.4%), $130.23 million in FY2022 (+54.6%) and $84.26 million in FY2021 (+47.8%).
- The five-year range for quarterly Research & Development is $21.58 million (Q3 2021) to $100.08 million (Q1 2026).
- Year-over-year, Research & Development has increased for 33 consecutive quarters, with growth averaging 37.2% over the last eight quarters.
- Over the past five years, the year-over-year growth in Research & Development ranged from 23.2% (Q2 2023) to 61.1% (Q2 2022).
- Business Quant data shows CRNX's Research & Development at $100.08 million (Q1 2026), $85.05 million (Q4 2025) and $90.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 99.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.85 Mn |
| Mar 31, 2026 | 100.08 Mn |
| Dec 31, 2025 | 85.05 Mn |
| Sep 30, 2025 | 90.46 Mn |
| Jun 30, 2025 | 80.30 Mn |
| Mar 31, 2025 | 76.24 Mn |
| Dec 31, 2024 | 66.57 Mn |
| Sep 30, 2024 | 61.91 Mn |
| Jun 30, 2024 | 58.34 Mn |
| Mar 31, 2024 | 53.34 Mn |
| Dec 31, 2023 | 45.58 Mn |
| Sep 30, 2023 | 43.84 Mn |
| Jun 30, 2023 | 40.64 Mn |
| Mar 31, 2023 | 38.47 Mn |
| Dec 31, 2022 | 36.99 Mn |
| Sep 30, 2022 | 31.99 Mn |
| Jun 30, 2022 | 33.00 Mn |
| Mar 31, 2022 | 28.25 Mn |
| Dec 31, 2021 | 24.60 Mn |
| Sep 30, 2021 | 21.58 Mn |
API Access
Crinetics Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();